HER2-EXPRESSING CANCERS

Clinical trials for HER2-EXPRESSING CANCERS explained in plain language.

Never miss a new study

Get alerted when new HER2-EXPRESSING CANCERS trials appear

Sign up with your email to follow new studies for HER2-EXPRESSING CANCERS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

New combo therapy tested for Tough-to-Treat HER2 cancers

Disease control Completed

This study tested whether combining two investigational drugs, zanidatamab and evorpacept, was safe and could help treat people with advanced HER2-expressing cancers that had worsened after standard treatments. The first part of the study focused on finding safe dose levels, and …

Matched conditions: HER2-EXPRESSING CANCERS

Phase: PHASE1, PHASE2 • Sponsor: Jazz Pharmaceuticals • Aim: Disease control

Last updated Mar 23, 2026 15:19 UTC

HER2-EXPRESSING CANCERS

Get alerted when new HER2-EXPRESSING CANCERS trials appear

New combo therapy tested for Tough-to-Treat HER2 cancers